###begin article-title 0
Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 536 539 536 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin</sub>
Neuronal ceroid lipofuscinoses (NCLs) comprise at least eight genetically characterized neurodegenerative disorders of childhood. Despite of genetic heterogeneity, the high similarity of clinical symptoms and pathology of different NCL disorders suggest cooperation between different NCL proteins and common mechanisms of pathogenesis. Here, we have studied molecular interactions between NCL proteins, concentrating specifically on the interactions of CLN5, the protein underlying the Finnish variant late infantile form of NCL (vLINCLFin).
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 308 316 308 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor</sub>
###xml 510 511 510 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
We found that CLN5 interacts with several other NCL proteins namely, CLN1/PPT1, CLN2/TPP1, CLN3, CLN6 and CLN8. Furthermore, analysis of the intracellular targeting of CLN5 together with the interacting NCL proteins revealed that over-expression of PPT1 can facilitate the lysosomal transport of mutated CLN5FinMajor, normally residing in the ER and in the Golgi complex. The significance of the novel interaction between CLN5 and PPT1 was further supported by the finding that CLN5 was also able to bind the F1-ATPase, earlier shown to interact with PPT1.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
We have described novel interactions between CLN5 and several NCL proteins, suggesting a modifying role for these proteins in the pathogenesis of individual NCL disorders. Among these novel interactions, binding of CLN5 to CLN1/PPT1 is suggested to be the most significant one, since over-expression of PPT1 was shown to influence on the intracellular trafficking of mutated CLN5, and they were shown to share a binding partner outside the NCL protein spectrum.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 385 386 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1049 1050 1049 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1096 1097 1096 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1098 1099 1098 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1233 1234 1233 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 67 75 <span type="species:ncbi:9606">children</span>
###xml 1136 1141 <span type="species:ncbi:10090">mouse</span>
Neuronal ceroid lipofuscinoses (NCLs) are the most common group of children's progressive neurodegenerative disorders with an estimated incidence of 1:12500 in the USA and Nordic countries and approximately 1:100 000 worldwide [reviewed in [1,2]]. NCL disorders are mostly recessively inherited, and to date, eight different genes have been characterized to underlie these diseases [3-5]. Despite having genetic heterogeneity, NCL diseases resemble each other both clinically and neuropathologically. The clinical course varies from severe congenital disease to milder adult-onset forms. NCLs are phenotypically expressed by progressive mental deterioration, blindness, epileptic seizures and premature death. The pathological findings of these lysosomal storage disorders include intracellular accumulation of autofluorescent lipopigment with variable ultrastructural appearance as well as progressive loss of neocortical neurons. The major component of the intracellular storage material is either the subunit c of the mitochondrial ATP synthase [6] or sphingolipid activator proteins A and D [5,7]. More recent analyses of different mouse models of NCL have exposed additional common features in the brain pathology [reviewed in [8]].
###end p 8
###begin p 9
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 775 778 775 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin</sub>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 933 935 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1080 1082 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1218 1220 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1302 1304 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1305 1307 1305 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1308 1310 1308 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1311 1313 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1446 1448 1446 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1449 1451 1449 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1778 1780 1778 1780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1325 1330 <span type="species:ncbi:9606">human</span>
###xml 1335 1340 <span type="species:ncbi:10090">mouse</span>
The proteins encoded by NCL genes are localized in different compartments of the secretory pathway. Palmitoyl protein thioesterase 1 (PPT1; CLN1), tripeptidyl-peptidase 1 (TPP1; CLN2) and cathepsin D (CLN10) are soluble lysosomal enzymes [9-11]. CLN3 and the recently identified MFSD8 (CLN7) are transmembrane proteins localizing mainly to the late endosomal/lysosomal compartments [4,12]. Two of the NCL proteins, CLN6 and CLN8, reside mainly in the ER [13,14]. Despite the fact that many NCL proteins were characterized already a decade ago, the physiological functions of most NCL proteins are still not known and neither are the molecular connections between them understood [15]. CLN5 is a glycoprotein disrupted in the Finnish variant late infantile form of NCL (vLINCLFin) [16,17]. The subcellular localization of overexpressed CLN5 has been studied in BHK-21, HeLa and COS-1 and cells, where it was found to be lysosomal [16,18]. In neuronal cells, CLN5 is also present in the cellular extensions, but the specific organelle localization in neurons is still unidentified [16]. PPT1/CLN1 and CLN3 are also found in neuronal axons, where CLN1 has been localized to synaptic vesicles and CLN3 to synaptosomes [19-21]. Controversial data has been reported about the solubility of the CLN5 protein [16,18,22,23], but both human and mouse CLN5 have been found in the mannose 6-phosphoproteome, supporting the presence of soluble CLN5 variants [24,25]. Overall, the CLN5 protein is not well conserved, lacks protein homologues and is currently poorly characterized. Very little is also known about the interactions between different NCL proteins. Vesa and co-workers have shown by co-immunoprecipitation and in vitro binding assays that CLN5 interacts with both CLN2 and CLN3 [23], but the result has not been verified.
###end p 9
###begin p 10
To obtain more knowledge of common pathways in NCLs, we examined the interactions of CLN5 with other NCL proteins utilizing pull-down and co-immunoprecipitation analyses. We report four novel interactions for CLN5 and show that PPT1/CLN1 and CLN5 are connected at the level of intracellular trafficking.
###end p 10
###begin title 11
Methods
###end title 11
###begin title 12
Recombinant CLN5-cDNA constructs
###end title 12
###begin p 13
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mCln5</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
Mouse Cln5-cDNA lacking the suggested signal sequence (aa 26-341) was cloned in frame with an N-terminal GST-tag in a pGEX2T vector (Amersham Biosciences). For the co-immunoprecipitation assay, the full-length mCln5-cDNA (aa 1-341) was cloned into the pcDNA3.1A/Myc-His expression vector (Invitrogen) to produce a CLN5 protein with a C-terminal tag. The trafficking-deficient human CLN5-TD (CLN5 flag330) protein was obtained by inserting an intramolecular flag sequence after amino acid 330 into the full-length CLN5 (aa 1-407) pCMV5 construct, using the QuickChange Site-Directed mutagenesis kit. All constructs were verified by sequencing.
###end p 13
###begin title 14
Cell culture, transfection and immunofluorescence analyses
###end title 14
###begin p 15
###xml 109 113 <span type="species:ncbi:9913">calf</span>
HeLa and COS-1 cells were cultured in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal calf serum (FCS) and 1% antibiotics (penicillin/streptomycin). For transient transfections, cells were plated on 6-well plates and the transfection was performed with Lipofectaminetrade mark 2000 (Gibco Life Technologies) or Fugene HD (Roche Diagnostics) transfection reagents according to manufacturers' instructions. For immunofluorescence analysis, transiently transfected cells were grown on coverslips, fixed with ice-cold methanol 48 h after transfection and stained with the specific antibodies described below. The labeled coverslips were mounted using GelMount (Biomeda Corp., Foster City, CA) and visualized using Leica DMR confocal microscope with TCS NT software (Leica Microscope and Scientific Instruments Group). Adobe Photoshop and Adobe Illustrator softwares were used for image processing. All transfection and immunofluorescence experiments were repeated at least three times.
###end p 15
###begin title 16
Antibodies
###end title 16
###begin p 17
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 61 67 <span type="species:ncbi:9986">rabbit</span>
###xml 133 143 <span type="species:ncbi:10141">guinea pig</span>
###xml 265 271 <span type="species:ncbi:9986">rabbit</span>
###xml 314 320 <span type="species:ncbi:9986">rabbit</span>
###xml 365 370 <span type="species:ncbi:10090">mouse</span>
###xml 542 548 <span type="species:ncbi:9986">rabbit</span>
###xml 587 592 <span type="species:ncbi:10090">mouse</span>
###xml 648 653 <span type="species:ncbi:10090">mouse</span>
###xml 802 807 <span type="species:ncbi:10090">mouse</span>
###xml 861 866 <span type="species:ncbi:10090">mouse</span>
###xml 955 960 <span type="species:ncbi:10090">mouse</span>
The human CLN5 protein was detected either with a polyclonal rabbit antibody (1RmI-4) raised against GST-mCLN5 (aa 40-284) or with a guinea pig antibody (1GmII-3) raised against GST-mCLN5 (aa 40-341) [16]. PPT1 and CLN2 were detected with anti-PPT1 antibodies (WB: rabbit polyclonal antibody 8414, 1:500 [19]; IF: rabbit polyclonal antibody AA-PPT1, 1:200 [26] and mouse anti-CLN2 antibody 8C4, 1:20 [27] kindly provided by Drs. Kida and Golabek (New York, USA). CLN3 was detected with the peptide antibody 385 [21]. CLN8 was detected with a rabbit peptide antibody 391 (1:200) [13] and mouse monoclonal anti-HA antibody (Boehringer Mannheim). The mouse monoclonal anti-LAMP-1 antibody H4A3 (WB, IF 1:200) was obtained from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa City). The mouse monoclonal anti-FLAG antibody was from Sigma and the mouse anti c-myc antibody (9E10) and the anti-his antibody from Santa Cruz Biotechnology. The mouse monoclonal PDI (Protein Disulfide Isomerase) antibody was obtained from Stressgen. The alpha- and beta-subunits of the mitochondrial ATP synthase were detected with monoclonal antibodies from Molecular Probes. The secondary antibodies used for the immunofluorescence analyses were from Jackson ImmunoResearch and HRP-conjugated antibodies used for Western blot detection were from DAKO.
###end p 17
###begin title 18
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 18
###begin p 19
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppt1</italic>
###xml 13 21 13 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;ex4</sup>
###xml 29 31 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 37 41 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 41 45 37 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 51 53 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
Cln1-/- (Ppt1Deltaex4) mice [28] and Cln5-/- mice [29] used in this study were maintained on a congenic C57/BL6J strain background. The study has been carried out following good practice in laboratory animal handling and the regulations for handling genetically modified organisms, and it was approved by the Laboratory Animal Care and Use Committee of the National Public Health Institute, Helsinki. Tissues for liver extraction were from adult mice.
###end p 19
###begin title 20
Quantitative Real-time PCR
###end title 20
###begin p 21
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 64 67 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1</italic>
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 376 380 376 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1</italic>
###xml 395 399 395 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 1549 1551 1516 1518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T </sub>
###xml 1559 1561 1526 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1588 1590 1555 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1646 1659 1613 1618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#916;&#916;CT</sup>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 996 1001 <span type="species:ncbi:10090">mouse</span>
Real-time PCR was performed as described in [29]. In short, Cln5-/-, Cln1-/- and wild-type cortices were prepared and total RNA was extracted using RNeasy Mini kit (Qiagen) according to the manufacturer's instructions, followed by quantification by spectrophotometry. To average out the inter-individual variability, RNA was extracted from the whole cortical area of four Cln5-/- mice, four Cln1-/- mice and four of their respective wt littermates and pooled together into two wild-type and two knock-out samples. To eliminate genomic DNA, RNA was treated with DNAse I (Roche, Mannheim, Germany). The RT reactions were carried out on 300 ng of RNA using TaqMan Reverse transcription kit with Random hexamer primers (Applied Biosystems, Foster City, CA) as recommended by the manufacturer. TaqMan Gene Expression Assays of selected genes were purchased from Applied Bio systems (CLN5 Mm00515002_m1, PPT1 Mm00727515_s1). The mRNA expression levels of these genes and a standard house-keeping gene, mouse TATA-box binding protein (Tbp, Mm 00446973_m1), were quantified using real-time PCR analysis (TaqMan chemistry) on an ABI prism 7700 sequence detection system (PE Applied Bioscience, Warrington, UK). The PCR reactions (25 mul) were carried out in triplicate with TaqMan Universal Master Mix according to the manufacturer's instructions using the following parameters: 50degreesC for 2 min, 95degreesC for 10 min, 50 cycles of 95degreesC for 15 sec, 60degreesC for 60 min. Relative levels of the selected genes were calculated using the DeltaDeltaCT method [30] as described previously [29]. The absolute change in expression level is given by 2-DeltaDeltaCT. For illustrative purposes, the value for the wt gene expression was set to 1 and CLN5 as well as PPT1 expression values are shown relative to that.
###end p 21
###begin title 22
GST pull-down assays
###end title 22
###begin p 23
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli </italic>
###xml 362 364 356 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 48 55 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
The GST-mCLN5 fusion construct was expressed in E. coli and purified by binding to the glutathione-Sepharose 4B beads (Amersham Biosciences) for 2 h at 4degreesC. For the search of NCL binding partners, cytosolic extracts of COS-1 cells were prepared by lysing the cells in lysis buffer (25 mM HEPES pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, 0.5 mM MgCl2 and protease inhibitors) and removing the cell debris by centrifugation. GST vector control and GST-mCLN5 fusion protein were incubated with 4 ml of COS lysates (~2 mg/ml) overnight at 4degreesC. The beads were washed five times with lysis buffer and the samples were separated by SDS-PAGE under reducing conditions, immunoblotted and probed for different NCL proteins.
###end p 23
###begin p 24
###xml 108 115 101 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">28-306 </sub>
###xml 116 118 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 233 237 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 237 241 230 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 248 252 241 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 364 365 357 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 378 380 371 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sub>
###xml 675 676 656 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 192 197 <span type="species:ncbi:10090">mouse</span>
###xml 214 219 <span type="species:ncbi:10090">mouse</span>
###xml 252 257 <span type="species:ncbi:10090">mouse</span>
The alpha- and beta-subunits of the mitochondrial ATP synthase were pulled down with GST-mCLN5 and GST-hPPT128-306 [31] from the enriched lysosomal/mitochondrial fraction originating from the mouse liver. Briefly, mouse liver of wt, Cln5-/- or Cln1-/- mouse was homogenized (1 g of liver in 5 ml of HB) in HB buffer (320 mM saccharose, 4 mM HEPES pH 7.4, 1 mM MgCl2, 0.5 mM CaCl2 + protease inhibitors) and centrifuged at 3500 rpm for 10 min at 4degreesC. The post-nuclear supernatant was transferred to clean tubes and centrifuged again at 14 000 rpm for 15 min at 4degreesC. The pellet was then dissolved with 1.5 ml of EB buffer (100 mM NaCl, 50 mM HEPES pH 7.4, 5 mM MgCl2, 0.5% Triton X-100 + protease inhibitors). The GST pull-downs were done by incubating 1 ml (2.5 mg/ml) of enriched liver lysosomal/mitochondrial fractions with different GST fusion proteins (GST, GST-mCLN5, GST-hPPT1) over night at 4degreesC. The beads were then carefully washed with the EB buffer. Samples were separated by SDS-PAGE, immunoblotted and probed for alpha- and beta-subunits. All pull-down experiments were repeated at least twice.
###end p 24
###begin title 25
Co-immunoprecipitation assay
###end title 25
###begin p 26
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 234 235 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
PPT1/CLN1 was transiently expressed together with mCLN5-myc/his or with an OPR1L-his [32] control protein in COS-1 cells. The cells were lysed into an immunoprecipitation buffer (IP buffer: 10 mM Hepes pH 7.4, 150 mM NaCl, 0.5 mM MgCl2, 10% glycerol, 0.5% Triton X-100, + protein inhibitor cocktail) and the cell debris was removed by centrifugation. Immunoprecipitation was done by adding a his-specific antibody (1 mug/ml) and incubating the samples on ice for three hours. Immunocomplexes were then captured by incubation with Protein A/G Plus agarose beads (Santa Cruz) over night at 4degreesC. Agarose beads were then gently centrifuged (3000 rpm for 30 sec.) and washed three times with the IP-buffer. Samples were separated by SDS-PAGE, immunoblotted and probed for PPT1/CLN1.
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
Interactions of CLN5 with other NCL proteins
###end title 28
###begin p 29
###xml 198 206 198 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">aa26-341</sup>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 844 845 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1387 1388 1387 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1505 1506 1505 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1666 1667 1666 1667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
###xml 264 269 <span type="species:ncbi:10090">mouse</span>
The possible interactions of CLN5 with other NCL proteins were investigated with GST pull-down experiments. A GST-CLN5 fusion protein expressing the mouse CLN5 lacking the signal sequence (GST-mCLN5aa26-341) was used to pull down endogenous NCL proteins from both mouse brain extract and HeLa cell lysates (Additional file 1). To avoid the possible false negative binding results due to low endogenous levels of most NCL proteins, the pull-downs were also prepared from lysates of COS-1 cells transiently transfected with different NCL proteins (Fig. 1). The bound proteins were identified by Western blot analyses. Vesa and co-workers have previously shown by co-immunoprecipitation and in vitro-binding assays that CLN5 interacts with CLN2 and CLN3 [23]. In our pull-down experiments, we could also capture CLN2 and CLN3 with GST-mCLN5 (Fig. 1), which was considered to serve as a positive control for our further pull-down analyses. The CLN2 antibody recognized both the 68 kDa precursor and the mature, lysosomal 48 kDa form of CLN2 [33] in the cell lysate, but only the mature form showed prominent binding with GST-mCLN5. This suggests that the interaction between CLN5 and CLN2 most likely occurs in the late endocytic compartments. Three novel interactions between NCL proteins were additionally discovered, as PPT1/CLN1, CLN6 and CLN8 were also shown to bind to GST-mCLN5 (Fig. 1). All proteins except CLN8 could also be pulled down endogenously from brain and HeLa cell lysates (Additional file 1). The specificity of the pull-down experiments was tested by using LAMP-1, a lysosomal membrane protein, as a control. It showed no binding to GST-mCLN5 (Fig. 1). After LAMP-1 detection, the membrane was reprobed with anti-CLN2 antibody as a positive control for the pull-down experiment (data not shown). Altogether, the GST-mCLN5 interactions found here cover both soluble and transmembrane NCL proteins residing both in the ER and the lysosomes, thus suggesting that CLN5 has the capacity to bind different NCL proteins at different cellular localizations. This observation indicates that CLN5 may play a role as a factor that connects different NCL proteins.
###end p 29
###begin p 30
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Interactions of CLN5 with other NCL proteins</bold>
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Interactions of CLN5 with other NCL proteins. The mouse Cln5-cDNA (coding for aa 26-341) was expressed as GST fusion protein and used to pull down NCL proteins from COS-1 cell lysates. PPT1, CLN3, CLN6-c-myc and CLN8-HA were transiently overexpressed in COS-1 cells and pulled down with GST-mCLN5 and GST vector control. CLN2 and LAMP-1 proteins were endogenous. The bound proteins were immunoblotted and detected with specific antibodies listed in Methods section.
###end p 30
###begin title 31
Analyses of intracellular trafficking of CLN5 together with the interacting proteins
###end title 31
###begin p 32
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 178 182 178 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 593 597 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 597 601 597 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 182 187 <span type="species:ncbi:10090">mouse</span>
To dissect the role of CLN5 interactions with other NCL proteins in vivo, we first compared the localization of the newly characterized interaction partners in wild type and Cln5-/- mouse fibroblasts [29]. Fibroblasts were transiently transfected with constructs producing different NCL proteins (CLN1, 3, 6 and 8, whereas CLN2 could be detected endogenously) and fluorescently labeled with antibodies against the NCL proteins as well as specific organelle markers. However, no differences in the localization of any of the interacting NCL proteins could be detected between the wild type and Cln5-/- cells (data not shown). We also studied the possible effects of simultaneous overexpression of wild type hCLN5 and the interaction partners on the protein localization in HeLa cells. Transient overexpression did not influence the localization of CLN1, CLN2, CLN6 or CLN8 (data not shown). The hydrophobic CLN3 was found in lysosomes, but was often detected also in the ER together with CLN5, most probably reflecting a folding defect in a situation in which two proteins are overexpressed (data not shown). This could reflect an overloading of the ER protein folding machinery.
###end p 32
###begin p 33
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2A-C</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2D-F</xref>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2G-I</xref>
###xml 1002 1006 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2J-L</xref>
###xml 1297 1301 1297 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A-C</xref>
###xml 1352 1356 1352 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3D-F</xref>
###xml 1373 1377 1373 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3G-I</xref>
To assess whether severe defects in the transport of CLN5 could affect the localization of any of the interacting proteins, co-expressions were performed using a trafficking-deficient hCLN5 polypeptide (CLN5-TD), representing a protein restricted to the ER. The intramolecular insertion of a flag-tag (CLN5-flag330) restrained the CLN5-TD polypeptide into the ER in HeLa cells (Fig. 2A-C). Interestingly, when the wild type PPT1/CLN1 was co-expressed with this ER-resident construct, it was also retained in the ER (Fig. 2D-F). To control the specificity of the observed restriction on PPT1 transport by CLN5, PPT1/CLN1 was also overexpressed together with trafficking-deficient CLN3-flag434 (data not shown) and ER-resident CLN6 (Fig. 2G-I). Neither of these proteins affected the lysosomal trafficking of PPT1/CLN1. The transport of CLN3 from the ER was also delayed when it was co-expressed with the ER-resident CLN5-TD; CLN3 was detected in the lysosomes, but was additionally seen in the ER (Fig. 2J-L). However, the effect was milder compared to that seen with PPT1/CLN1 and therefore was thought to result from problems in protein folding in the ER. Trafficking of the endogenous CLN2 was not altered due to overexpression of CLN5-TD and it was correctly transported to the lysosomes (Fig. 3A-C). As assumed, the ER-resident proteins CLN6 (Fig. 3D-F) and CLN8 (Fig. 3G-I) remained in the ER and were not detectably influenced by the transport defect of CLN5-TD.
###end p 33
###begin p 34
###xml 0 114 0 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Consequences of the ER-resident trafficking deficient CLN5 on the localization of PPT1/CLN1 and CLN3 in HeLa cells</bold>
###xml 450 453 450 453 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-C</bold>
###xml 545 548 545 548 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D-F</bold>
###xml 577 579 577 579 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E </bold>
###xml 718 721 718 721 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G-I</bold>
###xml 807 810 807 810 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">J-L</bold>
Consequences of the ER-resident trafficking deficient CLN5 on the localization of PPT1/CLN1 and CLN3 in HeLa cells. HeLa cells were transiently transfected with the trafficking deficient CLN5 (CLN5-TD) carrying the intramolecular flag-tag after aa 330, alone, or together with wild type PPT1 or CLN3. The cells were fixed with methanol 48 h post transfection, stained and analyzed by confocal microscopy. CLN5-TD co-localized with the ER marker PDI (A-C). When transfected together with PPT1, CLN5-TD retained the wild type PPT1 also in the ER (D-F), (compare the two cells in E positive for PPT1 with and without CLN5-TD), whereas overexpression of the ER resident CLN6 did not have an influence on PPT1 trafficking (G-I). The CLN5-TD partially affected also the lysosomal targeting of the wild type CLN3 (J-L). Scale bar 10 mum.
###end p 34
###begin p 35
###xml 0 115 0 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Consequences of the ER-resident trafficking deficient CLN5 on the localization of CLN2, CLN6 and CLN8 in HeLa cells</bold>
###xml 260 263 260 263 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-C</bold>
###xml 298 301 298 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D-F</bold>
###xml 312 315 312 315 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G-I</bold>
###xml 507 510 507 510 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-C</bold>
###xml 567 570 567 570 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D-F</bold>
###xml 582 585 582 585 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G-I</bold>
Consequences of the ER-resident trafficking deficient CLN5 on the localization of CLN2, CLN6 and CLN8 in HeLa cells. HeLa cells were transiently transfected alone with the trafficking deficient CLN5 (CLN5-TD) carrying the intramolecular flag-tag after aa 330 (A-C) or together with wild type CLN6 (D-F) or CLN8 (G-I). The cells were fixed with methanol 48 h post transfection, stained and analyzed by confocal microscopy. The CLN5-TD did not have an effect on the lysosomal localization of endogenous CLN2 (A-C) or on the overexpressed ER resident NCL proteins CLN6 (D-F) and CLN8 (G-I). Scale bar 10 mum.
###end p 35
###begin title 36
###xml 79 88 79 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
Overexpression of wild type PPT1/CLN1 rescues the lysosomal trafficking of CLN5FinMajor polypeptide
###end title 36
###begin p 37
###xml 194 198 194 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin </sub>
###xml 238 246 238 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor</sub>
###xml 307 316 307 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A-C</xref>
###xml 799 808 799 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 949 953 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4D-F</xref>
###xml 1026 1035 1026 1035 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 1157 1161 1157 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4G-K</xref>
###xml 1182 1183 1182 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1364 1373 1364 1373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 1505 1514 1505 1514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 1575 1576 1575 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1661 1670 1661 1670 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 1268 1273 <span type="species:ncbi:9606">human</span>
As the most dramatic influence on the localization of the binding partners of CLN5 was seen for PPT1/CLN1, it was of interest to study if the expression of CLN5 possessing the most common vLINCLFin disease-causing mutation (p. Y392X, CLN5FinMajor) would also influence the trafficking of PPT1/CLN1. The CLN5FinMajor mutation results in a truncated polypeptide lacking 16 amino acids from the C-terminus [17] and it has been demonstrated to localize to the ER and Golgi instead of lysosomes [18]. Importantly, this mutant protein represents an ER exit-competent CLN5, in contrast to the CLN5-TD which is a strict ER-resident. We first expressed the wild type PPT1 with wild type CLN5 in HeLa cells and found that the two proteins completely co-localized in the lysosomes (Fig. 4A-C). The mutated CLN5FinMajor polypeptides expressed alone did not show co-localization with the lysosomal marker, LAMP-1, but were retained in the ER in HeLa cells (Fig. 4D-F). Interestingly, simultaneous overexpression of wild type PPT1 with CLN5FinMajor resulted in a positive effect on the trafficking of the mutated CLN5, and both proteins were found in the lysosomes (Fig. 4G-K and Additional file 2). To verify the results obtained in HeLa cells, we repeated the experiments also in human neuroblastoma cells (SH-SY5Y). Simultaneous overexpression of wild type PPT1/CLN1 and CLN5FinMajor in SH-SY5Y cells again resulted in co-localization of the two proteins in LAMP-1 positive late endosomes/lysosomes, whereas the CLN5FinMajor expressed alone was detected only in the ER (Additional file 3). Wild type PPT1/CLN1 seemed thus to have a positive effect on the transport of CLN5FinMajor when overexpressed in the same cell, being able to facilitate the trafficking of the mutated CLN5 from the ER into the late endosomal compartments.
###end p 37
###begin p 38
###xml 23 32 23 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Consequence of the CLN5<sub>FinMajor </sub>disease mutation on the trafficking of PPT1/CLN1 in HeLa cells</bold>
###xml 176 179 176 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-C</bold>
###xml 189 198 189 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 205 208 205 208 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D-F</bold>
###xml 218 227 218 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 258 262 258 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin </sub>
###xml 294 297 294 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G-K</bold>
###xml 461 464 461 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A-C</bold>
###xml 476 485 476 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 590 593 590 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D-F</bold>
###xml 605 614 605 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 689 692 689 692 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G-K</bold>
Consequence of the CLN5FinMajor disease mutation on the trafficking of PPT1/CLN1 in HeLa cells. HeLa cells were transiently transfected with the wt CLN5 together with wt PPT1 (A-C), or CLN5FinMajor alone (D-F), or CLN5FinMajor carrying the most common vLINCLFin mutation together with wt PPT1 (G-K). The cells were fixed with methanol 48 h post transfection, stained and analyzed by confocal microscopy. The wt proteins co-localized with each other completely (A-C). When CLN5FinMajor was expressed alone, it was retained in the ER and did not co-localize with the lysosomal marker LAMP-1 (D-F). When CLN5FinMajor was co-expressed with wt PPT1, the proteins co-localized in the lysosomes (G-K). Scale bar 10 mum.
###end p 38
###begin title 39
PPT1/CLN1 mutants retained in the ER do not restrict the lysosomal trafficking of CLN5
###end title 39
###begin p 40
###xml 68 76 68 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor</sub>
###xml 251 254 251 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin</sub>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 312 317 312 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adult</sub>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 458 462 458 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin </sub>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A</xref>
###xml 480 486 480 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adult </sub>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A</xref>
###xml 929 933 929 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin </sub>
###xml 941 947 941 947 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adult </sub>
###xml 1086 1088 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5B</xref>
###xml 1260 1268 1260 1268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor</sub>
As PPT1/CLN1 was found to facilitate trafficking of the mutated CLN5FinMajor, we wanted to study whether it is a prerequisite for the lysosomal trafficking of CLN5. We overexpressed PPT1/CLN1 carrying either the most common INCL disease mutation (PPT1Fin, p. R122W) [34] or the adult-onset causing mutation (PPT1Adult, p. G108R) [35] together with the wt CLN5 in HeLa cells. The localization of the proteins was then studied by confocal microscopy. Both PPT1Fin (Fig. 5A) and PPT1Adult (data not shown, [26]) localized to the ER, whereas the wt CLN5 was found in the lysosomes (Fig. 5A). The mutated PPT1/CLN1 proteins were never detected in lysosomes suggesting that CLN5 lacks the positive targeting effect found in the opposite situation with wt PPT1/CLN1. This could, however, result from a defective interaction between the two proteins due to PPT1 mutations. To study this, we used GST-mCLN5 to pull down overexpressed PPT1Fin and PPT1Adult proteins from the COS-1 cell lysates. Both of the mutated PPT1/CLN1 proteins were pulled down with CLN5, similarly to the wt protein (Fig. 5B), demonstrating that the interaction between the two proteins was maintained. These data indicated that although PPT1/CLN1 can facilitate the lysosomal trafficking of CLN5FinMajor, CLN5 cannot rescue the restricted trafficking of the mutated PPT1/CLN1 to the lysosomes.
###end p 40
###begin p 41
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Consequences of the INCL disease mutations on the trafficking of CLN5</bold>
###xml 71 75 71 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A) </bold>
###xml 136 139 136 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin</sub>
###xml 331 334 331 334 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin</sub>
###xml 390 394 390 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin </sub>
###xml 432 436 431 435 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B) </bold>
###xml 513 517 512 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin </sub>
###xml 611 615 610 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin </sub>
Consequences of the INCL disease mutations on the trafficking of CLN5. (A) HeLa cells were transiently transfected with wt CLN5 and PPT1Fin, carrying the most common INCL causing mutation. Cells were fixed with methanol 48 h post transfection, stained and analyzed by confocal microscopy. When wt CLN5 was co-expressed with wt PPT1Fin, wt CLN5 was able to traffic to lysosomes, whereas PPT1Fin retained in the ER. Scale bar 10 mum. (B) The GST-mCLN5 was used to pull down PPT1 carrying INCL disease mutations (PPTFin or the adult-onset causing mutation) and wild type CLN1/PPT1 from COS-1 cell lysates. Both PPTFin and the adult-onset mutations maintained their interaction with CLN5.
###end p 41
###begin title 42
Co-immunoprecipitation and compensatory mRNA expression support the relationship between CLN1 and CLN5
###end title 42
###begin p 43
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1 </italic>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5 </italic>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6A</xref>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
Both our pull-down and trafficking experiments indicated a strong interaction between CLN1 and CLN5, but since this interaction was not detected in the previous co-immunoprecipitation assay [23], we wanted to strengthen our data with additional experiments. Therefore, we also performed a co-immunoprecipation assay and analyzed the mRNA expression of the binding partner protein both in Cln1 and Cln5 deficient mice. In the co-immunoprecipitation assay, PPT1/CLN1 was expressed together with mCLN5-myc/his or with a control protein ORP1L-his [32] in COS-1 cells. mCLN5-myc/his and ORP1L-his were immunoprecipitated with a his-specific antibody followed by PPT1/CLN1 detection by Western blot analysis. PPT1/CLN1 co-immunoprecipitated with CLN5, especially the tri- and diglycosylated forms, supporting the binding of the premature ER forms of PPT1/CLN1 [26] to CLN5. The control protein ORP1L showed no binding to PPT1/CLN1 (Fig. 6A).
###end p 43
###begin p 44
###xml 0 38 0 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Association between CLN5 and PPT1/CLN1</bold>
###xml 40 44 40 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A) </bold>
###xml 360 364 360 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B) </bold>
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 423 427 423 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 438 442 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1</italic>
###xml 442 446 442 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5 </italic>
###xml 707 712 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppt1 </italic>
###xml 843 847 843 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 847 851 847 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 951 955 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1</italic>
###xml 955 959 955 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
Association between CLN5 and PPT1/CLN1. (A) COS-1 cells were transiently transfected with PPT1/CLN1 together with mCLN5-myc/his or ORP1L-his. Co-immunoprecipitation was performed with a his-specific antibody, followed by Western blot detection for PPT1/CLN1. CLN5 was found to bind specifically with PPT1/CLN1, confirming the interaction between the proteins. (B) RNA was extracted from the whole cortical area of four Cln5-/- mice, four Cln1-/- mice and four of their respective wt littermates and pooled together into two wild-type and two knock-out samples. Real time RT-PCR was then performed to measure expression of the two NCL proteins. The value for the wt gene expression was set to 1 and Cln5 and Ppt1 expression values are shown relative to that. Expression of CLN1 (black columns) was over two-fold up-regulated in the 4-month-old Cln5-/- mice compared to that of the wt. The expression of CLN5 (gray columns) was only slightly altered in Cln1-/- mice of the same age.
###end p 44
###begin p 45
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1 </italic>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5 </italic>
###xml 280 285 280 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1 </italic>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5 </italic>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5 </italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1 </italic>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6B</xref>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
Real time PCR was performed from the cortices of wt, Cln1 and Cln5 deficient mice to detect the possible dependence of the disruption of one binding partner on the expression of the other. Analyses of mRNA expression levels in brain tissues showed significant upregulation of the Cln1 mRNA in the four-month old Cln5 deficient mice, indicating a possible compensatory response. The mRNA levels of Cln5 were only slightly upregulated in the brain tissue of the Cln1 deficient mice (Fig. 6B). Altogether, these results strengthened our novel findings and suggested a possible functional connection between CLN1 and CLN5 proteins.
###end p 45
###begin title 46
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Interaction of CLN5 with the subunits of F1-ATP synthase
###end title 46
###begin p 47
###xml 101 102 101 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 216 217 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 397 398 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 442 443 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 538 539 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 649 653 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1</italic>
###xml 653 657 646 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 661 665 654 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 665 669 658 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 909 910 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 331 336 <span type="species:ncbi:10090">mouse</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
We have recently shown that PPT1/CLN1 co-purifies in a large protein complex and interacts with the F1-complex of ATP synthase [26,31]. Due to our novel findings, we tested whether CLN5 would also interact with the F1-complex. We used GST-mCLN5 to pull-down proteins from an enriched lysosomal/mitochondrial fraction prepared from mouse liver. Interestingly, both alpha- and beta-subunits of the F1-complex showed interaction with CLN5 (Fig. 7). To test whether PPT1 or CLN5 require each other for their respective interactions with the F1-complex, the experiment was repeatedly performed using lysosomal/mitochondrial fractions extracted from both Cln1-/- and Cln5-/- mice lacking the respective proteins. The beta-subunit was able to bind both GST-hPPT1 in the absence of CLN5 and GST-mCLN5 in the absence of PPT1, indicating that the proteins interact with the beta-subunit independent of each other (Fig. 7). These results show that in addition to an interaction between PPT1/CLN1 and CLN5, the proteins share another binding partner not belonging to the group of NCL proteins.
###end p 47
###begin p 48
###xml 0 73 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Interaction of CLN5 with the &#945;- and &#946;-subunits of the ATP synthase</bold>
###xml 244 248 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1</italic>
###xml 248 252 241 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 256 261 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5 </italic>
###xml 261 265 254 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 418 423 <span type="species:ncbi:10090">mouse</span>
Interaction of CLN5 with the alpha- and beta-subunits of the ATP synthase. GST-hPPT1 and GST-mCLN5 fusion proteins were used to pull down interacting proteins from enriched lysosomal/mitochondrial fraction extracted from the liver of wild type Cln1-/- and Cln5 -/- mice. The bound proteins were analyzed by Western blot using monoclonal antibodies for alpha- and beta-ATP synthase. Load = 10 mug of total protein from mouse liver extract.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 783 784 783 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 735 740 <span type="species:ncbi:10090">mouse</span>
Clinical and neuropathological similarities in NCL disorders may result from functional redundancy or co-operation of different NCL proteins. Initial evidence of co-operation has previously been obtained from activity measurements and gene expression analyses. For example, CLN2/TPP1 activity has been shown to be elevated in other forms of NCL [23,36,37]. Furthermore, the mRNA expression levels of a variety of NCL genes have been reported to be altered in different NCLs [22]. Recent studies of animal models have further supported a common mechanism in the disease pathogenesis of the NCLs. Selective loss of interneurons, early defects on thalamocortical neuron survival as well as early glial responses are detected in different mouse models as well as in large animal models [8,38]. Molecular interactions between NCL proteins have also been reported previously [23,39]. Here we continued the search for NCL protein interactions and their intracellular consequences. We demonstrate that CLN5 has molecular connections to at least to five other NCL proteins, namely CLN1/PPT1, CLN2/TPP1, CLN3, CLN6 and CLN8, suggesting a central role for CLN5 in the NCL network.
###end p 50
###begin p 51
###xml 1160 1162 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 1334 1336 1334 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 350 357 <span type="species:ncbi:9606">patient</span>
Mutations of CLN5 and consequent trafficking defects can result in functional consequences on the interacting proteins, as well as in changes in their distribution. Most NCL proteins are not, however, detectable endogenously by immunofluorescence analyses using the currently available antibodies and therefore this hypothesis could not be tested in patient fibroblasts. However, simultaneous overexpression of binding partners with the modified, transport incompetent CLN5-TD (CLN5-flag330) construct suggested that the interaction between PPT1/CLN1 and CLN5 is strong and occurs already in the ER, where the interactions between CLN5 and the two ER resident NCL proteins, CLN6 and CLN8, would also naturally occur. Since CLN5 resides in the lumen of intracellular organelles, interaction between CLN5 and the transmembrane proteins must be mediated by the lumenal domains of these proteins. The finding that NCL interactions can occur already in the ER is important since previous studies have also suggested that the ER is an important organelle for the function and/or trafficking of NCL proteins. For example, CLN3 carrying the most common JNCL mutation [40] has been reported to preserve a significant function in the ER. Although the mutated CLN3 is retained in the ER, it was shown to be able to affect the size of lysosomes [41]. Furthermore, our data suggest that TPP1/CLN2, another lysosomal enzyme, is likely to interact with CLN5 only in the late endosomes/lysosomes. This was supported both by the interaction analysis and the unaffected transport of CLN2. Therefore, the present data suggest that interactions between CLN5 and other NCL proteins can occur along the secretory pathway, and the interactions are not strictly dependent on the steady-state localization or the solubility of the NCL proteins.
###end p 51
###begin p 52
###xml 192 201 192 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FinMajor </sub>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 1052 1054 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 1333 1335 1327 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
Based on our trafficking experiments, the main focus was on the interaction between PPT1/CLN1 and CLN5. Unlike the transport deficient, strictly ER-resident CLN5-TD, the ER exit competent CLN5FinMajor did not prevent the lysosomal trafficking of PPT1 but rather, PPT1 was able to facilitate the trafficking of the mutated CLN5 from the ER and Golgi to the lysosomes. Lysosomal proteins have also previously been shown to assist each other in their lysosomal trafficking. For example, the CLC7 chloride transporter, involved in an NCL-like disorder in mouse, has been shown to facilitate the transport of Ostm1 to the lysosomes, where the proteins act together in lysosomal chloride transport [42]. It was also recently demonstrated that the lysosomal membrane protein LIMP-2 is required for the mannose 6-phosphate receptor-independent targeting of beta-glucocerebrosidase. Interestingly, the overexpression of LIMP-2 was also able to facilitate the transport of the mutated, trafficking deficient beta-glucocerebrosidase from the ER to the lysosomes [43]. Both PPT1 and CLN5 are soluble intravesicular proteins and are not able to interact with cytoplasmic sorting and transport machinery per se, like CLC7 and LIMP-2. However, trafficking of CLN1/PPT1 has been reported to show properties different from classic lysosomal enzymes [26] and we have recently discovered that also CLN5 can use M6PR-independent pathways for its lysosomal trafficking (our unpublished observations). Therefore, it is possible that the formation of the CLN1-CLN5 complex may be important for utilizing other trafficking pathways than the classical M6PR pathway. In which circumstances this is required in vivo, remains to be studied in further experiments.
###end p 52
###begin p 53
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1</italic>
###xml 271 275 271 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 283 287 283 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 658 663 658 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1 </italic>
###xml 675 679 675 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 679 683 679 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 912 913 912 913 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 941 942 941 942 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1029 1031 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1061 1062 1061 1062 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1138 1142 1138 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1</italic>
###xml 1142 1146 1142 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/- </sup>
###xml 1161 1163 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1438 1440 1438 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 1441 1443 1441 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 1459 1461 1459 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 1462 1464 1462 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 148 153 <span type="species:ncbi:10090">mouse</span>
###xml 180 185 <span type="species:ncbi:9606">human</span>
###xml 287 292 <span type="species:ncbi:10090">mouse</span>
###xml 683 688 <span type="species:ncbi:10090">mouse</span>
###xml 1146 1151 <span type="species:ncbi:10090">mouse</span>
A close connection between PPT1/CLN1 and CLN5 has already been suggested in previous studies. The proteins share similar expression patterns in the mouse brain and in the prenatal human brain [16,21,44,45]. Our recent global gene expression profiling analyses of the Cln1-/- and Cln5-/- mouse brains implicated a common defective pathway mediated by phosphorylation and potentially affecting the maturation of axons and neuronal growth cones [46]. Here, we provide further evidence for a tight relationship between the two proteins by showing not only the interaction between the proteins but also, demonstrating significantly increased expression levels of Cln1 mRNA in the Cln5-/- mouse brain tissue. This suggests a possible compensatory role for PPT1 in CLN5 deficiency. Functional connection of CLN5 and PPT1 is also suggested by the shared interaction partner not belonging to the NCL protein family, the F1-ATP synthase. The ectopic F1-ATP synthase has been shown to function as an apoA-I receptor on the plasma membrane [47] and both the amount of the F1-complex as well as the uptake of apoA-I have been shown to be increased in Cln1-/- mouse neurons [31]. Therefore, both PPT1 and CLN5 could be connected to the maintenance of lipid homeostasis. In general, accumulating evidence has indicated dysregulated lipid metabolism in different forms of NCLs and several NCL proteins have been functionally linked to lipid metabolism [[48,49], reviewed in [50-52]].
###end p 53
###begin title 54
Conclusion
###end title 54
###begin p 55
###xml 645 648 645 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fin</sub>
###xml 664 669 664 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5 </italic>
###xml 713 718 713 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln1 </italic>
###xml 962 963 962 963 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 736 741 <span type="species:ncbi:10090">mouse</span>
In this study, we show novel interactions between the neuronal ceroid lipofuscinosis protein CLN5 and five other NCL proteins. Consequently, our study strengthens the long-term hypothesis of a common cellular pathway behind the NCLs and suggests that different mutations in a given NCL protein may lead to different pathological outcomes through variable distinct effects on the NCL protein network. The strongest interaction was detected between CLN5 and PPT1/CLN1, and PPT1/CLN1 was shown to be able to contribute to the intracellular trafficking of the mutated CLN5, the phenomenon, which may be important when planning the therapy for vLINCLFin. Deficiency of Cln5 was also shown to result in upregulation of Cln1 expression in the mouse brain, suggesting a dependency for CLN1/PPT1 over CLN5. For the first time, the two NCL proteins were shown to share an interaction partner outside the NCL protein spectrum, since CLN5 and PPT1 both interacted with the F1-complex of the ATP synthase. This finding may be important in characterization of the cellular functions of the NCL proteins.
###end p 55
###begin title 56
Authors' contributions
###end title 56
###begin p 57
AL carried out the immunofluorescent analyses, participated in the design of the study and drafted the manuscript. CvS participated in the performance of the immunofluorescent analyses, the study design and drafting of the manuscript. CvS also carried out the mRNA expression analyses. CH carried out most of the GST pull-down experiments together with MLS and TS. AJ and AK conceived of the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 57
###begin title 58
Supplementary Material
###end title 58
###begin title 59
Additional file 1
###end title 59
###begin p 60
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Interaction of CLN5 with endogenous NCL proteins in HeLa cells</bold>
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cln5</italic>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 288 294 <span type="species:ncbi:9986">rabbit</span>
###xml 367 373 <span type="species:ncbi:9986">rabbit</span>
Interaction of CLN5 with endogenous NCL proteins in HeLa cells. The mouse Cln5-cDNA was expressed as a GST fusion protein and used for pull down analyses of endogenous NCL proteins from HeLa cell lysates. The bound proteins were immunoblotted and detected with specific antibodies: CLN2, rabbit polyclonal antibody 7951 [23], CLN3, polyclonal 385 antibody [21] PPT1, rabbit polyclonal antibody 8414 [19], and with anti-CLN6 antibody, which was a generous gift from Dr. S. Mole (London, UK) (Wheeler et al. Am J Hum Genet 70, 2002).
###end p 60
###begin p 61
Click here for file
###end p 61
###begin title 62
Additional file 2
###end title 62
###begin p 63
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Co-expression of the mutated CLN5 and wtPPT1 in HeLa cells</bold>
Co-expression of the mutated CLN5 and wtPPT1 in HeLa cells. HeLa cells were transiently transfected with the mutated CLN5Fin (A) and wt CLN1/PPT1 (B). The cells were fixed with methanol 48 h post transfection, stained and analyzed by confocal microscopy. The Golgi complex is stained with GM130 (C). CLN5Fin and wt PPT co-localized only partially with the Golgi complex (D-F). Scale bar 10 mum.
###end p 63
###begin p 64
Click here for file
###end p 64
###begin title 65
Additional file 3
###end title 65
###begin p 66
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Facilitated lysosomal trafficking of the mutated CLN5 by PPT1 overexpression in SH-SY5Y cells</bold>
###xml 95 100 <span type="species:ncbi:9606">Human</span>
Facilitated lysosomal trafficking of the mutated CLN5 by PPT1 overexpression in SH-SY5Y cells. Human neuroblastoma cells (SH-SY5Y), were transiently transfected with wt CLN1/PPT1 and CLN5-Fin, carrying the most common vLINCL(Fin) causing mutation (A-E), or with CLN5-Fin alone (F-H). The cells were fixed with methanol 48 h post transfection, stained and analyzed by confocal microscopy. When CLN5-Fin was co-expressed with wt PPT1, CLN5-Fin was able to traffic to lysosomes with PPT1 (A-E). When CLN5-Fin was expressed alone, it retained in the ER (F-H). Scale bar 10 mum.
###end p 66
###begin p 67
Click here for file
###end p 67
###begin title 68
Acknowledgements
###end title 68
###begin p 69
The authors wish to express their gratitude to Auli Toivola and Kaija Antila for superb technical assistance. Riitta Paakkanen is thanked for the help in the immunofluorescence studies. Robert M. Badeau is acknowledged for revising the language of the manuscript. This study has been supported by the European Commission (LSHM-CT-2003-503051 to AJ); Academy of Finland (213506 to AJ); Arvo and Lea Ylppo Foundation (to AL), Rinnekoti Foundation (to AL); Sigrid Juselius Foundation (to AJ); The Finnish Cultural Foundation (to CvS).
###end p 69
###begin article-title 70
The neuronal ceroid-lipofuscinoses: from past to present
###end article-title 70
###begin article-title 71
Neuronal ceroid-lipofuscinoses in childhood
###end article-title 71
###begin article-title 72
Molecular genetics of the NCLs -- status and perspectives
###end article-title 72
###begin article-title 73
The Novel Neuronal Ceroid Lipofuscinosis Gene MFSD8 Encodes a Putative Lysosomal Transporter
###end article-title 73
###begin article-title 74
###xml 44 49 <span type="species:ncbi:9606">human</span>
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis
###end article-title 74
###begin article-title 75
Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)
###end article-title 75
###begin article-title 76
Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis
###end article-title 76
###begin article-title 77
Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis
###end article-title 77
###begin article-title 78
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis
###end article-title 78
###begin article-title 79
Association of mutations in a lysosomal protein with classical late- infantile neuronal ceroid lipofuscinosis
###end article-title 79
###begin article-title 80
Evolution in the structure and function of aspartic proteases
###end article-title 80
###begin article-title 81
Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease
###end article-title 81
###begin article-title 82
The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum
###end article-title 82
###begin article-title 83
CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein
###end article-title 83
###begin article-title 84
Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins
###end article-title 84
###begin article-title 85
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain
###end article-title 85
###begin article-title 86
CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis
###end article-title 86
###begin article-title 87
Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein
###end article-title 87
###begin article-title 88
Palmitoyl protein thioesterase 1 is targeted to the axons in neurons
###end article-title 88
###begin article-title 89
Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL)
###end article-title 89
###begin article-title 90
CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease
###end article-title 90
###begin article-title 91
###xml 41 48 <span type="species:ncbi:9606">patient</span>
Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 deficiency
###end article-title 91
###begin article-title 92
Neuronal Ceroid Lipofuscinoses Are Connected at Molecular Level: Interaction of CLN5 Protein with CLN2 and CLN3
###end article-title 92
###begin article-title 93
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human brain mannose 6-phosphate glycoproteome: a complex mixture composed of multiple isoforms of many soluble lysosomal proteins
###end article-title 93
###begin article-title 94
Identification of novel lysosomal matrix proteins by proteome analysis
###end article-title 94
###begin article-title 95
Glycosylation, transport, and complex formation of palmitoyl protein thioesterase 1 (PPT1) - distinct characteristics in neurons
###end article-title 95
###begin article-title 96
###xml 43 48 <span type="species:ncbi:9606">human</span>
Distribution of tripeptidyl peptidase I in human tissues under normal and pathological conditions
###end article-title 96
###begin article-title 97
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with Ppt1(Deltaex4) mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons
###end article-title 97
###begin article-title 98
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging
###end article-title 98
###begin article-title 99
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
###end article-title 99
###begin article-title 100
Deficiency of the INCL protein Ppt1 results in changes in ectopic F1-ATP synthase and altered cholesterol metabolism
###end article-title 100
###begin article-title 101
The oxysterol-binding protein homologue ORP1L interacts with Rab7 and alters functional properties of late endocytic compartments
###end article-title 101
###begin article-title 102
###xml 65 70 <span type="species:ncbi:9606">human</span>
Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I
###end article-title 102
###begin article-title 103
Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis
###end article-title 103
###begin article-title 104
###xml 103 111 <span type="species:ncbi:9606">patients</span>
Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease
###end article-title 104
###begin article-title 105
Specific alterations in levels of mannose 6-phosphorylated glycoproteins in different neuronal ceroid lipofuscinoses
###end article-title 105
###begin article-title 106
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases
###end article-title 106
###begin article-title 107
###xml 93 98 <span type="species:ncbi:9940">sheep</span>
###xml 132 137 <span type="species:ncbi:9940">sheep</span>
A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA
###end article-title 107
###begin article-title 108
Neuronal ceroid lipofuscinosis: a common pathway?
###end article-title 108
###begin article-title 109
Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium
###end article-title 109
###begin article-title 110
A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis
###end article-title 110
###begin article-title 111
ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function
###end article-title 111
###begin article-title 112
LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase
###end article-title 112
###begin article-title 113
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Developmental expression of palmitoyl protein thioesterase in normal mice
###end article-title 113
###begin article-title 114
###xml 127 132 <span type="species:ncbi:9606">human</span>
CLN-1 and CLN-5, genes for infantile and variant late infantile neuronal ceroid lipofuscinoses, are expressed in the embryonic human brain
###end article-title 114
###begin article-title 115
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Brain gene expression profiles of Cln1 and Cln5 deficient mice unravels common molecular pathways underlying neuronal degeneration in NCL diseases
###end article-title 115
###begin article-title 116
Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis
###end article-title 116
###begin article-title 117
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Palmitoyl protein thioesterase 1 (Ppt1)-deficient mouse neurons show alterations in cholesterol metabolism and calcium homeostasis prior to synaptic dysfunction
###end article-title 117
###begin article-title 118
Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux
###end article-title 118
###begin article-title 119
From genes to systems: new global strategies for the characterization of NCL biology
###end article-title 119
###begin article-title 120
CLN3P, the Batten's disease protein, is a novel palmitoyl-protein Delta-9 desaturase
###end article-title 120
###begin article-title 121
TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains?
###end article-title 121

